FDA Brief

Warning letters Food

FDA warning letter to

Yuyao City Boss Vegetable Factory Co. Ltd.

High riskIssued Nov 28, 2025Posted Mar 3Human Foods Program

Yuyao City Boss Vegetable Factory failed to keep or fabricated processing records for U.S.-shipped acidified mustard stems.

What happened

FDA inspected the facility from June 16 to June 17, 2025 and found no processing or production records showing that acidified mustard stems shipped to the United States between April 28, 2024 and June 9, 2025 followed its filed scheduled process (the required processing steps). During the walk-through, the investigator saw the Quality Control Manager and administrative staff creating and backdating multiple records, and the company admitted that critical-factor monitoring records were being fabricated. FDA later placed the firm and its whole, shredded, and sliced acidified mustard stems on Import Alert #99-38 (detention without physical examination) on October 23, 2025.

What FDA found

  1. The firm did not keep processing or production records showing that its acidified mustard stems met the critical factors in its filed scheduled process.

    21 CFR 114.100(b)
  2. Employees created and backdated finished-product pH results, production logs, raw material and batching records, and sterilization and critical-factor monitoring records during the inspection.

    21 CFR 114.100(b)
  3. The firm could not show that its acidified mustard stems were made according to its filed scheduled processes.

    21 CFR 108.25 and 21 CFR Part 114
  4. A finished-product pH testing record submitted with the firm's response appeared to accept a result that did not match the filed scheduled process.

    21 CFR Part 114

What FDA wants

Notify FDA in writing within 15 working days of receipt of the specific steps and corrections taken, including processing records for at least five lots of acidified mustard stems produced over at least five days; if corrective actions cannot be completed, state the reason and the time within which they will be done. FDA also strongly recommends engaging a qualified consultant to audit CGMP (current good manufacturing practice) compliance.

Who should pay attention

  • U.S. importers and distributors of acidified mustard stems
  • brands sourcing shelf-stable acidified vegetables from Chinese processors
  • supplier verification and food safety teams at retailers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natural Essentials, Inc.

    FDA warns Natural Essentials over OTC drug manufacturing violations, including inadequate failing test result investigations and missing component identity tests.

    High risk
  2. Pritam International Private Limited

    Pritam International, an Indian OTC drug maker, was cited for CGMP violations, falsified lab data, unsafe color additive, and DEG/EG testing gaps.

    High risk
  3. Conroe Welding Supply, Inc.

    FDA warns Conroe Welding Supply over medical oxygen manufacturing failures, including untested batches and a container with 99% (b)(4).

    High risk
  4. SnugZ USA, Inc.

    SnugZ USA, an OTC drug maker in West Jordan, Utah, was cited for releasing drugs after retesting failed batches until they passed.

    High risk